Citation 162372

DUVERNAY,VH: EUBANKS,D: PERALES,R: PRESTAYKO,AW: CROOKE,ST:. (1982). THE ANTITUMOR EFFECTS OF ANTHRACYCLINES. 2. THE STEREOSPECIFICITY OF THE CARBOMETHOXY GROUP AT POSITION 10 OF THE CLASS 2 ANTHRACYCLINE MOLECULE.. 21()

Citation Details

Title	THE ANTITUMOR EFFECTS OF ANTHRACYCLINES. 2. THE STEREOSPECIFICITY OF THE CARBOMETHOXY GROUP AT POSITION 10 OF THE CLASS 2 ANTHRACYCLINE MOLECULE.
Authors	DUVERNAY,VH: EUBANKS,D: PERALES,R: PRESTAYKO,AW: CROOKE,ST:
Year	1982
Volume	21
Issue

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (4)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MARCELLOMYCIN	ACTIVE
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MARCELLOMYCIN	ACTIVE
3	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MARCELLOMYCIN	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MARCELLOMYCIN	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MARCELLOMYCIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MIMIMYCIN	INACTIVE
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MIMIMYCIN	INACTIVE
3	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MIMIMYCIN	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MIMIMYCIN	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MIMIMYCIN	None

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MUSETTAMYCIN	ACTIVE
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MUSETTAMYCIN	ACTIVE
3	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MUSETTAMYCIN	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MUSETTAMYCIN	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MUSETTAMYCIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COLLINEMYCIN	INACTIVE
2	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COLLINEMYCIN	INACTIVE
3	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COLLINEMYCIN	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COLLINEMYCIN	WEAK ACTIVITY
5	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COLLINEMYCIN	INACTIVE

Show SPARQL Queries (1)